242 related articles for article (PubMed ID: 19887608)
1. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Leng X; Ding T; Lin H; Wang Y; Hu L; Hu J; Feig B; Zhang W; Pusztai L; Symmans WF; Wu Y; Arlinghaus RB
Cancer Res; 2009 Nov; 69(22):8579-84. PubMed ID: 19887608
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis.
Berger T; Cheung CC; Elia AJ; Mak TW
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2995-3000. PubMed ID: 20133630
[TBL] [Abstract][Full Text] [Related]
4. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.
Li SH; Hawthorne VS; Neal CL; Sanghera S; Xu J; Yang J; Guo H; Steeg PS; Yu D
Cancer Res; 2009 Dec; 69(24):9163-8. PubMed ID: 19951994
[TBL] [Abstract][Full Text] [Related]
6. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin 2 promotes lung metastasis of murine breast cancer cells.
Shi H; Gu Y; Yang J; Xu L; Mi W; Yu W
J Exp Clin Cancer Res; 2008 Dec; 27(1):83. PubMed ID: 19077278
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activation.
Guo H; Jin D; Chen X
Mol Endocrinol; 2014 Oct; 28(10):1616-28. PubMed ID: 25127375
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.
Viau A; El Karoui K; Laouari D; Burtin M; Nguyen C; Mori K; Pillebout E; Berger T; Mak TW; Knebelmann B; Friedlander G; Barasch J; Terzi F
J Clin Invest; 2010 Nov; 120(11):4065-76. PubMed ID: 20921623
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin 2, the TNF-like receptor TWEAKR and its ligand TWEAK act downstream of NFAT1 to regulate breast cancer cell invasion.
Gaudineau B; Fougère M; Guaddachi F; Lemoine F; de la Grange P; Jauliac S
J Cell Sci; 2012 Oct; 125(Pt 19):4475-86. PubMed ID: 22767506
[TBL] [Abstract][Full Text] [Related]
14. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.
Borkham-Kamphorst E; van de Leur E; Zimmermann HW; Karlmark KR; Tihaa L; Haas U; Tacke F; Berger T; Mak TW; Weiskirchen R
Biochim Biophys Acta; 2013 May; 1832(5):660-73. PubMed ID: 23376114
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
[TBL] [Abstract][Full Text] [Related]
17. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.
Chakraborty S; Kaur S; Guha S; Batra SK
Biochim Biophys Acta; 2012 Aug; 1826(1):129-69. PubMed ID: 22513004
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin 2 promotes breast cancer progression.
Yang J; Bielenberg DR; Rodig SJ; Doiron R; Clifton MC; Kung AL; Strong RK; Zurakowski D; Moses MA
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3913-8. PubMed ID: 19237579
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes.
Zhang Y; Foncea R; Deis JA; Guo H; Bernlohr DA; Chen X
PLoS One; 2014; 9(5):e96997. PubMed ID: 24818605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
